Literature DB >> 17970806

Involvement of E-cadherin, beta-catenin, Cdc42 and CXCR4 in the progression and prognosis of cutaneous melanoma.

M G Tucci1, G Lucarini, D Brancorsini, A Zizzi, A Pugnaloni, A Giacchetti, G Ricotti, G Biagini.   

Abstract

BACKGROUND: A key event in cancer metastasis is the migration of tumour cells from their original location to a secondary site. The development of melanoma may be viewed as a consequence of the disruption of homeostatic mechanisms in the skin of the original site.
OBJECTIVES: To investigate whether dysregulation of cell motility (Cdc42 expression), escaping the control of cell-cell and cell-matrix interactions (E-cadherin, beta-catenin expression), enhances melanoma progression, and whether chemokine receptors (CXCR4) mediate cell migration and activation during invasion and metastasis development.
METHODS: The immunohistochemical expression of Cdc42, E-cadherin, beta-catenin and CXCR4 was investigated in 30 patients with surgically treated nodular melanoma, 18 alive and disease free and 12 with a fatal outcome due to metastatic disease.
RESULTS: E-cadherin expression was significantly reduced (P < 0.05) and cytoplasmic beta-catenin was increased in the patients who had died compared with disease-free individuals, while membrane expression of beta-catenin was similar in the two groups. Patients with fatal outcome had increased Cdc42 (P < 0.01) and CXCR4 (P < 0.05). In this group a positive correlation was found between melanocytic Cdc42 expression and Breslow thickness (r = 0.598, P < 0.05) and between CXCR4 expression and Breslow thickness (r = 0.583, P < 0.05).
CONCLUSIONS: Findings suggest that primary cutaneous melanoma with a high Breslow thickness is characterized by tumour cells with high motility and invasion ability, in line with the hypothesis that low E-cadherin levels and overexpression of Cdc42 and CXCR4 could be prognostic markers of poor outcome.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17970806     DOI: 10.1111/j.1365-2133.2007.08246.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  49 in total

1.  miR-200c/Bmi1 axis and epithelial-mesenchymal transition contribute to acquired resistance to BRAF inhibitor treatment.

Authors:  Shujing Liu; Michael T Tetzlaff; Tao Wang; Ruifeng Yang; Lin Xie; Gao Zhang; Clemens Krepler; Min Xiao; Marilda Beqiri; Wei Xu; Giorgos Karakousis; Lynn Schuchter; Ravi K Amaravadi; Weiting Xu; Zhi Wei; Meenhard Herlyn; Yuan Yao; Litao Zhang; Yingjie Wang; Lin Zhang; Xiaowei Xu
Journal:  Pigment Cell Melanoma Res       Date:  2015-05-16       Impact factor: 4.693

2.  Early Steps of Jaagsiekte Sheep Retrovirus-Mediated Cell Transformation Involve the Interaction between Env and the RALBP1 Cellular Protein.

Authors:  Margaux Monot; Alexandra Erny; Barbara Gineys; Sophie Desloire; Christine Dolmazon; Anne Aublin-Gex; Vincent Lotteau; Fabienne Archer; Caroline Leroux
Journal:  J Virol       Date:  2015-06-03       Impact factor: 5.103

Review 3.  Cdc42 in oncogenic transformation, invasion, and tumorigenesis.

Authors:  Kristy Stengel; Yi Zheng
Journal:  Cell Signal       Date:  2011-04-16       Impact factor: 4.315

4.  Silencing of CDC42 inhibits neuroblastoma cell proliferation and transformation.

Authors:  Sora Lee; Brian T Craig; Carmelle V Romain; Jingbo Qiao; Dai H Chung
Journal:  Cancer Lett       Date:  2014-09-28       Impact factor: 8.679

5.  High Expression of Cell Division Cycle 42 Promotes Pancreatic Cancer Growth and Predicts Poor Outcome of Pancreatic Cancer Patients.

Authors:  Dejun Yang; Yu Zhang; Yajun Cheng; Liang Hong; Changming Wang; Ziran Wei; Qingping Cai; Ronglin Yan
Journal:  Dig Dis Sci       Date:  2017-02-08       Impact factor: 3.199

6.  Systems-wide analysis of K-Ras, Cdc42, and PAK4 signaling by quantitative phosphoproteomics.

Authors:  Florian Gnad; Amy Young; Wei Zhou; Karen Lyle; Christy C Ong; Matthew P Stokes; Jeffrey C Silva; Marcia Belvin; Lori S Friedman; Hartmut Koeppen; Audrey Minden; Klaus P Hoeflich
Journal:  Mol Cell Proteomics       Date:  2013-04-22       Impact factor: 5.911

7.  Genetic variants in the genes encoding rho GTPases and related regulators predict cutaneous melanoma-specific survival.

Authors:  Shun Liu; Yanru Wang; William Xue; Hongliang Liu; Yinghui Xu; Qiong Shi; Wenting Wu; Dakai Zhu; Christopher I Amos; Shenying Fang; Jeffrey E Lee; Terry Hyslop; Yi Li; Jiali Han; Qingyi Wei
Journal:  Int J Cancer       Date:  2017-06-01       Impact factor: 7.396

Review 8.  Chemokine signaling in cancer: one hump or two?

Authors:  Joshua B Rubin
Journal:  Semin Cancer Biol       Date:  2008-10-17       Impact factor: 15.707

9.  In vitro and in vivo anticancer properties of a Calcarea carbonica derivative complex (M8) treatment in a murine melanoma model.

Authors:  Fernando S F Guimarães; Lucas F Andrade; Sharon T Martins; Ana P R Abud; Reginaldo V Sene; Carla Wanderer; Inés Tiscornia; Mariela Bollati-Fogolín; Dorly F Buchi; Edvaldo S Trindade
Journal:  BMC Cancer       Date:  2010-03-25       Impact factor: 4.430

10.  A comprehensive genome-wide analysis of melanoma Breslow thickness identifies interaction between CDC42 and SCIN genetic variants.

Authors:  Amaury Vaysse; Shenying Fang; Myriam Brossard; Qingyi Wei; Wei V Chen; Hamida Mohamdi; Lynda Vincent-Fetita; Patricia Margaritte-Jeannin; Nolwenn Lavielle; Eve Maubec; Mark Lathrop; Marie-Françoise Avril; Christopher I Amos; Jeffrey E Lee; Florence Demenais
Journal:  Int J Cancer       Date:  2016-07-23       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.